|
Originally published In Press as doi:10.1074/jbc.M212380200 on June 3, 2003
J. Biol. Chem., Vol. 278, Issue 35, 33105-33119, August 29, 2003
Gene Structure of the Human Metabotropic Glutamate Receptor 5 and Functional Analysis of Its Multiple Promoters in Neuroblastoma and Astroglioma Cells*
Corrado Corti ,
Richard W. E. Clarkson ¶,
Luca Crepaldi ||,
Cinzia F. Sala ,
John H. Xuereb and
Francesco Ferraguti || **
From the
Cambridge Brain Bank Laboratory,
Department of Pathology, University of Cambridge, Level 3 Laboratory Block
Addenbrooke's Hospital, Hills Road, CB2 2QQ Cambridge, the
¶Department of Pathology, University of
Cambridge, Tennis Court Road, CB2 1QP Cambridge, United Kingdom, the
||Department of Pharmacology, University of
Innsbruck, Peter Mayr Strasse 1a, A-6020 Innsbruck, Austria, and the
Department of Biology, Psychiatry Centre of
Excellence in Drug Discovery, GlaxoSmithKline Medicines Research Centre, Via
Fleming 4, 37135 Verona, Italy
The metabotropic glutamate receptor 5 (mGluR5) has a discrete tissue
expression mainly limited to neural cells. Expression of mGluR5 is
developmentally regulated and undergoes dramatic changes in association with
neuropathological disorders. We report the complete genomic structure of the
mGluR5 gene, which is composed of 11 exons and encompasses 563 kbp. Three
clusters of multiple transcription initiation sites located on three distinct
exons (IA, IB, and II), which undergo alternative splicing, have been
identified. The 5'-flanking regions of these exons were isolated and,
using a luciferase reporter gene assay, shown to possess active promoter
elements in SKN-MC neuroblastoma and U178-MG astroglioma cells. Promoter IA
was characterized by a CpG island; promoter IB contained a TATA box, and
promoter II possessed three active Oct-1-binding sites. Preferential
luciferase activity was observed in SKN-MC concomitant with differential DNA
binding activity to several responsive elements, including CREB, Oct-1, C/EBP,
and Brn-2. Exposure to growth factors produced enhanced expression of
promoters IB and II in astroglioma cells and activation of NF- B. These
results suggest that alternative 5'-splicing and usage of multiple
promoters may contribute regulatory mechanisms for tissue- and
context-specific expression of the mGluR5 gene.
Received for publication, December 5, 2002
, and in revised form, May 9, 2003.
* The costs of publication of this article were defrayed in part by the
payment of page charges. This article must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section 1734
solely to indicate this fact.
**
To whom correspondence should be addressed: Dept. of Pharmacology, University
of Innsbruck, Peter Mayr Strasse 1a, A-6020 Innsbruck, Austria. Tel.:
43-512-507-3704; Fax: 43-512-507-2783; E-mail:
francesco.ferraguti{at}uibk.ac.at.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. Crepaldi, C. Lackner, C. Corti, and F. Ferraguti
Transcriptional Activators and Repressors for the Neuron-specific Expression of a Metabotropic Glutamate Receptor
J. Biol. Chem.,
June 15, 2007;
282(24):
17877 - 17889.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|